Pharmaceutical Investing Reata Announces Receipt of $30 Million Milestone Payment From Kyowa Hakko Kirin
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
